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The R2TP chaperone cooperates with HSP90 to integrate newly synthesized proteins into
multi-subunit complexes, yet its role in tissue homeostasis is unknown. Here, we generated
conditional, inducible knock-out mice for Rpap3 to inactivate this core component of R2TP in
the intestinal epithelium. In adult mice, Rpap3 invalidation caused destruction of the small
intestinal epithelium and death within 10 days. Levels of R2TP substrates decreased, with
strong effects on mTOR, ATM and ATR. Proliferative stem cells and progenitors deficient for
Rpap3 failed to import RNA polymerase II into the nucleus and they induced p53, cell cycle
arrest and apoptosis. Post-mitotic, differentiated cells did not display these alterations,
suggesting that R2TP clients are preferentially built in actively proliferating cells. In addition,
high RPAP3 levels in colorectal tumors from patients correlate with bad prognosis. Here, we
show that, in the intestine, the R2TP chaperone plays essential roles in normal and tumoral
proliferation.
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The R2TP complex was first discovered in Saccharomycescerevisiae as an HSP90 co-chaperone1. HSP90 folds hun-dreds of substrate proteins (also called “clients”) into their
native, active state2. The chaperone activity of HSP90 is coupled
with its ATPase cycle and is regulated by a number of co-factors
called co-chaperones. These co-chaperones aid client loading and
regulate the HSP90 ATPase cycle2. R2TP is an HSP90 co-
chaperone but is unusual for two reasons: first, it is composed of
four different subunits; second, it is specialized in quaternary
protein folding, i.e., it enables the incorporation of clients into
multi-subunit complexes (for review3). In mammals, R2TP is
composed of a heterodimer between PIH1D1 and RPAP3, which
associates with a heterohexamer of RUVBL1 and RUVBL2
(Fig. 1a). PIH1D1 and RPAP3 are both involved in substrate
recognition4,5 while RPAP3 also recruits the chaperones HSP90
and HSP706,7. RUVBL1 and RUVBL2 are related AAA+
ATPases that also have chaperone activity8,9. Multiple contacts
between the PIH1D1:RPAP3 heterodimer and the RUVBL1/2
heterohexamer allow regulation of their ATPase activity7,10–12.
Importantly, the RPAP3:PIH1D1 heterodimer is specific to R2TP
whereas RUVBL1/2 are also part of other complexes such as the
chromatin remodelers INO80 and SRCAP13. In mammals, R2TP
also associates with a set of six prefoldins and prefoldin-like
proteins, possibly to help protein folding. Altogether, R2TP
associated with prefoldins has been termed the PAQosome, for
Particle for Arrangement of Quaternary structure3.
The first documented R2TP clients were the small nucleolar
ribonucleoparticles (snoRNPs), which are required for the
maturation of ribosomal RNAs14,15. These particles can be
grouped into two families, the C/D and H/ACA snoRNPs, each
family being characterized by a set of four proteins, which
assembles with a variety of small nucleolar RNAs. Later on, other
R2TP substrates have been identified, including the U4 and
U5 spliceosomal snRNPs16–18, the nuclear RNA polymerases19,20,
MRE1121, and the PI3K-like kinases (PIKKs) mTOR, ATR, ATM,
DNA-PK, and SMG-122. R2TP clients thus include several mul-
timeric cellular complexes with crucial roles in transcription,
ribosome biogenesis, DNA repair and cell growth3,23, yet the role
of R2TP in tissue homeostasis has not been studied. Most of our
knowledge about R2TP originates from work in S.cerevisiae,
mammalian cell lines or in vitro studies with recombinant pro-
teins. In S.cerevisiae, R2TP is mostly required under stress
conditions14,24,25. In D. melanogaster, knockdown of Spag,
RPAP3 ortholog, compromises early development and germline
stem cells, but not somatic organogenesis nor homeostasis26,27.
The role of HSP90 on tissue development is also poorly docu-
mented. Constitutive knockout (KO) murine models showed that
one cytosolic paralog of HSP90 was necessary for spermatogen-
esis while the other one was essential for early development28,29.
Conditional models to characterize the role of HSP90 and R2TP
in specific tissues are still missing.
In this study, we chose to address the role of R2TP in the
intestine, the most dynamically self-renewing tissue in adult
mammals. The intestine has a well-defined architecture, which is
particularly amenable to study cell proliferation and
differentiation30. Briefly, active stem cells called Crypt Base
Columnar (CBC) stem cells reside at the bottom of intestinal
crypts, where they divide to either self-renew, or give rise to
progenitors (see below). Progenitors migrate through the tran-
sient amplifying (TA) compartment to undergo several division
rounds and then differentiate. Differentiated cells migrate
towards the villus tip, where they ultimately undergo apoptosis
and are shed off the tissue31. Progenitors can differentiate into
enterocytes, responsible for water and nutrient absorption and
compose most of the small intestine epithelium. Alternatively,
progenitors differentiate into one of the secretory subtypes.
Among these, the goblet cells are the most represented. These
cells produce a lubricant protective mucus layer, and their density
increases from the duodenum to the colon. In the small intestine,
CBC stem cells also generate long-lived Paneth cells (3–6 weeks),
which secrete anti-microbial peptides and maintain crypt niche
conditions (for review31).
In this work, we generated murine models bearing a condi-
tional KO allele of Rpap3 to study the role of R2TP in intestinal
homeostasis. Indeed, RPAP3 is central to R2TP, bridging together
HSP90, HSP70, PIH1D1, and RUVBL1/27,10–12. Our work
uncovered a crucial role of R2TP in CBC stem cells and pro-
genitors, where it couples the assembly of key cellular machi-
neries with proliferation. In agreement with a link between R2TP
and cell proliferation, we found that high RPAP3 expression in
human colorectal cancer (CRC) tissues is associated with shorter
disease-free survival (DFS) in patients.
Results
Rpap3 is an essential gene in mice. To generate Rpap3 murine
models, we tested different recombinant murine Embryonic Stem
cells (ES cells) available from the KOMP consortium (Supple-
mentary Fig. 1a, b). In the Rpap3wtsi allele, a strong acceptor
splice site is introduced before exon 7. The resulting mRNA
encodes a Rpap3wtsi protein truncated after the first TPR domain,
at amino acid 223, followed by a selection cassette and the bac-
terial β-galactosidase gene (Supplementary Fig. 1a, b). Site-
specific recombination at the Rpap3 locus was confirmed by
Southern blot in the H10 clone (Supplementary Fig. 1c). Injection
of H10 ES cells into blastocysts generated 3 chimeras with
germinal transmission. Intercrossing of Rpap3wtsi/+ animals did
not yield any homozygous Rpap3wtsi/wtsi animal, suggesting that
this truncated Rpap3 allele is homozygous lethal (0/34 pups;
Supplementary Fig. 1a, b).
We used the β-galactosidase cassette to characterize Rpap3
expression. In the small intestine of Rpap3wtsi/+ animals, we
detected β-galactosidase activity exclusively at the bottom of the
crypts, intercalated between lacZ negative cells (Fig. 1b). This
could correspond to either CBC stem cells or Paneth cells (see
below for a schematic representation of the small intestinal
crypts). Pih1d1 interacts with Rpap3, and this interaction is
crucial for Pih1d1 stability and R2TP activity32. Pih1d1 is
detected in CBC stem cells and progenitors but not in Paneth
cells nor differentiated cells of the villus (Fig. 1c and below for a
schematic representation of the crypts). In the colon, LacZ
activity is weak, Pih1d1 is undetectable and both are absent from
the stroma (Fig. 1c). Overall, R2TP expression is restricted to
proliferative cells.
Rpap3 is required for small intestine maintenance. To generate
a conditional KO strain, Rpap3wtsi/+ mice were crossed with mice
carrying a transgene encoding the Flipase Flp33. In the progeny,
excision of the Flp-in cassette produced a Rpap3 allele with exon
7 flanked by loxP sites (Supplementary Fig. 1a). Rpap3flox mRNA
encodes a protein identical to wild-type Rpap3. Indeed, there was
no bias in transmission nor any obvious phenotype in Rpap3flox/
flox mice. Excision of exon 7 by Cre-recombinase produces a
Rpap3Δ7 mRNA with a premature termination codon in exon 8,
predicted to be degraded by the nonsense-mediated decay path-
way (Supplementary Fig. 1a, b).
To obtain a constitutive deletion of Rpap3 in the intestinal
epithelium, Rpap3flox/flox mice were crossed with villin-Cre
(VilCre) transgenic mice. The VilCre transgene encodes a
constitutively active Cre that is specifically expressed in the
epithelial cells of the small and large intestine34. We were unable
to generate homozygous VilCre; Rpap3flox/flox animals (0/100
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pups; Supplementary Fig. 1a), showing that the absence of Rpap3
in the intestinal epithelium is lethal. To bypass this problem, we
turned to an inducible CreERT2 under the control of the same
promotor (VilCreERT2). This Cre-recombinase is also specifically
expressed in the intestinal epithelium but needs to be activated by
tamoxifen34. VilCreERT2; Rpap3flox/flox animals were healthy and
did not present any obvious phenotype. We then injected
intraperitoneally two doses of tamoxifen separated by an interval
of 24 h in 8-week-old mice because the intestine is fully developed
at this age. This yielded an efficient recombination, already
detectable 1 day after the first injection and only in the small
intestine and colon epithelium but not in any of the other organs
tested (Supplementary Fig. 1d, e). As a consequence, Rpap3
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strongly reduced in colon, 5 days after the first tamoxifen
injection (Fig. 1d).
VilCreERT2; Rpap3flox/flox mice showed no obvious phenotype
during the first days following tamoxifen injection but suffered
from an important weight loss from day 6 onwards, such that
most females and males had to be sacrificed from day 8 to 10
(Fig. 1e). The small intestines from these animals were shorter
than those of controls and displayed a massive swelling with a
transparent liquid or blood (Fig. 1f, g). Histological analysis
revealed no alteration in the small intestine of VilCreERT2;
Rpap3fox/flox mice within the first 6 days. At day 7, however, villi
epithelial cells presented an altered morphology with surface
enterocyte disorganization and focal crowding (Fig. 2a, b red
square). At day 8, there was a severe destruction of the small
intestinal architecture with villous atrophy and tufts of extruding
epithelium (Fig. 2b). In contrast, the intestines of the VilCreERT2;
Rpap3flox/+ mice did not show any phenotype (Fig. 2b),
suggesting that under normal conditions, one allele of wild-type
Rpap3 is sufficient to maintain tissue homeostasis.
Rpap3 promotes cell proliferation within the epithelium. To
understand the basis for this rapid degeneration of the intestinal
epithelium, we characterized Ki67 expression. Ki67 marks pro-
liferative cells which are, in the intestine, the CBC stem cells and
progenitors from the TA compartment (Fig. 3a, b). Immunos-
taining revealed a loss of Ki67 in the crypts of VilCreERT2;
Rpap3flox/flox animals 7 days after tamoxifen injection (Figs. 2b,
3c). To directly monitor cell cycling, BrdU was injected into the
mouse peritoneum 2 h before sacrifice. BrdU is a nucleoside
analog incorporated into the DNA during S-phase. BrdU staining
was comparable from day 1 to day 6 in the crypts of control and
VilCreERT2; Rpap3flox/flox animals. At day 7 however, there were
significantly less BrdU+ cells (Fig. 3d, e). This is coherent with the
loss of Ki67 staining and confirms cycle arrest in the crypts and
the TA compartment of the mutant animals. At day 8, the
atrophic small bowel mucosa showed remnants of crypt glands
with some Ki67+ cells (Fig. 2b, black arrowheads). Overall, such
epithelium destruction, with remnants of Ki67+ crypt glands,
phenocopies TCF4 loss35. TCF4 is the transcription factor that
integrates Wnt signaling to sustain CBC stemness program36.
This suggests that R2TP may be required for both CBC and
progenitors.
To directly analyze CBC stem cells, we performed immunostain-
ing for Olfm4, a trans-membrane protein commonly used for CBC
identification37 (Fig. 4a, b and Supplementary Fig. 4a). Olfm4 stain-
ing was similar between control and VilCreERT2; Rpap3flox/flox mice
from day 4 to day 6 after tamoxifen injection. However, at days 7
and 8, Olfm4 expression was undetectable in most VilCreERT2;
Rpap3flox/flox crypts (Fig. 4a, b and Supplementary Fig. 2a), in
agreement with the loss of Ki67+ staining (Figs. 2b, 3c). In the
crypts, CBC stem cells intercalate between larger differentiated cells,
called Paneth cells. These cells are Ki67− and recognizable with the
lysozyme marker (Fig. 4c, d) or by their typical supranuclear
eosinophilic (cytoplasmic) granules stained by Hematoxylin/Eosin
(HE; Fig. 3c). In marked contrast to CBC stem cells, Paneth cells
were detected in a comparable manner in the crypts of control and
VilCreERT2; Rpap3flox/flox mice until day 8 (Figs. 3c, 4d). Altogether,
these observations confirmed that the loss of Rpap3 induces the
rapid disappearance of proliferating stem cells and progenitors, but
not of differentiated Paneth cells.
Interestingly, we observed cells with round, dense nuclei,
resembling apoptotic cells, in the crypts of small intestines
deficient for Rpap3. We verified this by immunostaining for
cleaved caspase 3, a well-established marker of apoptosis. In
control mice, few cleaved caspase 3-positive cells were visible at
the tip of some villi, where they are normally shed. We detected
significantly more cleaved caspase 3+ cells in the crypts of
tamoxifen-injected VilCreERT2; Rpap3flox/flox mice (Fig. 4e).
These apoptotic cells were observed in the crypts and TA
compartment, but not at the villi tips, as observed in normal
epithelia (Fig. 4f). Thus, Rpap3 deletion eventually induces
apoptosis of CBC stem cells and progenitors.
Rpap3 stabilizes clients of diverse families. A prominent R2TP
client is Rpb1, the largest subunit of RNA polymerase II (RNA
PolII)19,20. R2TP incorporates neo-translated Rpb1 within RNA
PolII in the cytoplasm, after which it is imported into the
nucleus19. As expected, immunohistochemistry (IHC) for Rpb1
displayed a nuclear staining in control intestines (Fig. 5a). In
VilCreERT2; Rpap3flox/flox animals, 6 days after the first tamoxifen
injection, when the epithelial architecture was still preserved,
Rpb1 accumulated in the cytoplasm of CBCs and TA progenitors,
but remained nuclear in differentiated epithelial cells, including
Paneth cells (Fig. 5a). This suggested that Rpap3 is necessary to
assemble RNA PolII in the proliferative compartment (Fig. 5b).
Misfolded HSP90 clients are usually degraded38, so we
determined the expression levels of R2TP clients in VilCreERT2;
Rpap3flox/flox animals at day 6. R2TP was initially characterized as
an assembly factor for the box C/D snoRNPs, and in particular it
chaperones NOP58, one of the four core proteins in these
particles15,39. Western blot analysis of crypt cell lysates showed a
near twofold reduction of NOP58 levels in extracts from
VilCreERT2; Rpap3flox/flox animals, as compared to controls
(Fig. 5c). R2TP stabilizes other non-coding RNPs in HeLa cells,
Fig. 1 Rpap3 deletion compromises the small intestine and mouse survival. a Schematic representation of R2TP with its four subunits (RPAP3, PIH1D1, and
the RUVBL1/2 heterohexamer). RPAP3 is the core subunit that contacts directly HSP90, PIH1D1 and RUVBL1/2. b β galactosidase activity in Rpap3wtsi/+
small intestines (top) and colon (bottom), as compared to negative controls (n= 2). Scale bars= 50 μm are identical for all images. c IHC of Pih1d1 in the
small intestine. Counter coloration of DNA with hematoxylin, with magnification (bottom). Top picture: bar represents 50 μm. Inset: arrows point to CBC
stem cells, intercalated between Paneth cells with distinctive granules in the cytoplasm; bar is 20 μm. Micrograph is representative of n= 3. d Depletion of
Rpap3 after tamoxifen injection. Western blots were revealed with antibodies against the indicated proteins in extracts of the jejunum (left) and the colonic
(right) epitheliums of RPAP3flox/flox controls (blue) or VilCreERT2; RPAP3flox/flox animals (red), 5 days after the first tamoxifen injection. Each lane was loaded
with the lysate obtained from a single animal and were verified for n= 12 small intestines and 8 colons, in three independent experiments. Molecular sizes
are indicated on the right. e Individual weight variations in females (top panel) and males (bottom panel) of tamoxifen treated VilCreERT2; RPAP3flox/flox
animals (red curves, n= 6 females and n= 5 males) and RPAP3flox/flox controls (blue curves, n= 8 females and n= 6 males). Individual weights were set at
100% for each animal at day 0, and analyzed by two-way ANOVA (genotype affects weights with p < 0.0001 in male and females) and Bonferroni’s post hoc
multiple comparison tests (**p < 0.01; ***p < 0.001; ****p < 0.0001—see Source Data). f Length of small intestines and colons from VilCreERT2; RPAP3flox/flox
mice (red points) and controls (blue points) measured at day 8 and day 10 of females (top, n= 3) and males (bottom, n= 4) were analyzed by two-tailed
unpaired t test with Welch’s correction (females: *p= 0.0177, t= 4.750, df= 3; males: ***p= 0.0001, t= 14.14, df= 4). Statistics data represent individual
assays with mean ± S.E.M. g Representative images of small intestine (white arrowheads) from VilCreERT2; RPAP3flox/flox animals, which were filled with liquid
(left panel) or blood (right panel) from day 8 to 10; a control organ is shown above. Source data are provided as a “Source Data file”.
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including the U5 snRNP, a splicing ribonucleoparticle that
includes the proteins PRPF8 and EFTUD217,18. Expression of
these proteins was reduced by nearly twofold in KO animals,
showing their dependency on R2TP in the small intestine
(Fig. 5c). HSP90 and R2TP are thought to stabilize clients only
before their assembly, and the extreme stability of snoRNPs and
snRNPs may explain this moderate but consistent decrease
observed here for their components40.
In mammals, PIKKs consist of six structurally related proteins
(ATR, ATM, DNA-PK, mTOR, TRRAP, and SMG1). PIKKs are
stabilized by the trimeric co-chaperone TTT32,41–43 and in
murine fibroblasts, TTT recruits R2TP to assemble PIKKs with
their partners22. By Western blot, we observed again a strong
diminution of ATR and ATM, the primary sensors of DNA
damage, as well as of mTOR, which activates translation and cell
proliferation in response to nutriment availability (Fig. 5d). These
results show that R2TP participates in the stabilization of ATR,
ATM, and mTOR. Yet, staining for γH2AX, a marker of DNA
damage, was similar in control and KO tissues (Supplementary
Fig. 3a). In contrast to the other PIKKs, TRRAP level did not
vary, either because R2TP does not chaperone TRRAP or because
it is a very stable protein.
Interestingly, in control tissues, these R2TP substrates are
concentrated in the crypts rather than in the villi. This was
observed for the U3 box C/D snoRNP (Supplementary Fig. 3b)
and components of the U5 snRNP, as well as ATR
50 µ m
day 0   1 day 6         day 7         day 8         
tamoxifen mice analysisa








Fig. 2 Rpap3 is necessary to small intestine integrity. a Schematic representation of the experimental setting: 8-week-old mice of the indicated genotype
received two sequential injections of tamoxifen 24 h apart, and were analyzed 6 to 8 days after the first injection. b Pictures of jejunum tissue sections
stained with HE (left) or by IHC with anti-Ki67 antibodies (right panels—Ki67 signal is brown) at different days after the first tamoxifen injection. Black
arrowheads indicate remnants of crypt glands with Ki67+ cells observed at day 8. Scale bar is identical for all panels, and is 50 μm as shown in control HE
panel. Each panel is representative of 8 to 12 animals from three independent experiments.
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(Supplementary Fig. 3c). Altogether, these data suggest that R2TP
assembles cellular machineries mainly in the CBCs and
progenitors.
R2TP KO triggers p53-dependent and independent apoptosis.
Cell stress, including DNA damage and ribosome biogenesis
defects, stabilize p53, which in turn arrests cell cycle and induces
apoptosis. We observed a strong increase of p53 levels at day 6 in
the crypts and TA compartment of KO mice (Fig. 6a, Supple-
mentary Fig. 4a). Mutually exclusive staining for p53 or lysozyme
confirmed that the induction of p53 occurs in CBCs and
progenitors but not in Paneth cells (Fig. 6b and Supplementary
Fig. 4b).
To address the role of p53 in epithelium degeneration
following the loss of R2TP activity, we generated double KO
VilCreERT2; Rpap3flox/flox; Trp53fox/flox mice. We verified that
adding floxed alleles did not alter the kinetics of Rpap3
recombination, which was already detected 16 h after tamoxifen
injection (Supplementary Fig. 4c). Accordingly, the phenotype of
Rpap3 deletion was unaffected by hemizygous deletion of Trp53
as VilCreERT2; Rpap3flox/flox; Trp53 flox/+ mice phenocopied
VilCreERT2; Rpap3flox/flox; Trp53+/+ mice (hereafter referred to as
“Rpap3 KO”). As reported before, invalidation of Trp53 alone did
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not cause any noticeable phenotype44,45 (Fig. 6c and Supplemen-
tary Fig. 6d). However, double KO mice showed a transient
rescue. At day 6, the intestinal epithelium from VilCreERT2;
Rpap3flox/flox; Trp53fox/flox mice appeared normal, with regular
Ki67 crypt staining, unlike that of Rpap3 single KO mice (Fig. 6c).
At day 7, the epithelium from double KO mice started shrinking,
with partial loss of Ki67 staining, while that of single Rpap3 KO
mice were strongly disorganized (Fig. 6c). Finally, at day 8, the
epithelium from both single Rpap3 and double KO showed
similar strong villus blunting (Fig. 6c). Staining for p53 and Rpb1
confirmed the near total penetrance of Trp53 and Rpap3 deletion
(Supplementary Fig. 4d and Fig. 6d). We detected cleaved caspase
3 and typical round apoptotic cells in both the double Trp53;
Rpap3 KO and the single Rpap3 KO crypts, but not in control nor
p53 KO crypts (Fig. 6e). Altogether, these results show that
inactivation of Rpap3 induces p53 expression, cell cycle arrest and
apoptosis. Still, sustained defective R2TP activity results in
epithelium degeneration even in absence of p53.
Rpap3 functions in the colon as in the small intestine. Deple-
tion of the Rpap3 protein was effective in both the small intestine
and the colon (Fig. 1d). Yet, colons were not shorter in Rpap3 KO
mice (Fig. 1f), nor was their architecture modified until day 8, as
observed by staining with Periodic Acid Schiff (PAS), Ki67, BrdU,
and CD44v6 labeling of colonic stem cells46 (Fig. 7a and Sup-
plementary Fig. 5a, b). We analyzed R2TP chaperone activity in
the colon by performing Western blots. This revealed a small
diminution of R2TP substrates in the colon, mostly visible for
mTOR and ATM. This diminution was less pronounced than that
in the small intestine (Fig. 7b and Supplementary Fig. 5c). It was
not accompanied by any detectable accumulation of Rpb1 in the
cytoplasm (Supplementary Fig. 5d), nonetheless p53 was induced
at the bottom of the crypt, as well as apoptosis (Fig. 7a, c and
Supplementary Fig. 5e). This suggests that the small defects
occurring in the colon are sufficient to trigger p53 activation, but
not to induce a visible phenotype at the tissue level.
To analyze the role of R2TP in the differentiation of the small
intestine and the colonic crypts, we simultaneously generated
organoids from both tissues, using mice treated with tamoxifen to
delete Rpap3, as previously described47. Crypts prepared from
control small intestines grew to form organoids that budded after
72 h in culture. In contrast, organoids prepared from KO mice
degenerated from 48 h on, with no observable budding,
confirming the essential role of Rpap3 for the survival and
differentiation of the small intestinal crypts (Fig. 7d). In parallel,
control colonic organoids started differentiating at 72 h and
budded after 96 h in culture. Remarkably, colonic organoids from
Rpap3 KO mice also died without reaching the budding stage, at
72 h (Fig. 7d). Thus, R2TP is necessary for the survival and
differentiation of both, small intestinal and colonic organoids.
Rpap3 phenotypes mirrors cellular turnover. To reassess the
role of Rpap3 in the colon, we generated Lgr5-EGFP-IRES-
CreERT2; Rpap3flox/flox animals (Supplementary Fig. 6a). In these
mice, GFP and the tamoxifen-inducible Cre are both under the
control of the CBC‒specific Lgr5 promoter. This construct has a
mosaic expression restricted to a few GFP+ crypts48, allowing the
animals to survive and the comparison of Rpap3-deficient and
-expressing crypts in the same intestines. Indeed, tamoxifen
treated Lgr5-EGFP-IRES-CreERT2; Rpap3flox/flox mice did not
show any visible physiological alteration and could survive for
3 weeks at least. Co-staining for GFP and Rpb1 showed that, at
day 7, in the small intestine, Rpb1 accumulated in the cytoplasm
of CBC stem cells and progenitors from GFP+ crypts, but not in
GFP− crypts, nor in non-recombinant GFP+ crypts from Lgr5-
EGFP-IRES-CreERT2; Rpap3+/+ control mice (100% of GFP+
crypts had cytoplasmic Rpb1; Fig. 8b and Supplementary Fig. 6a).
At day 10, GFP+ crypts had been eliminated from the small
intestine of Lgr5-EGFP-IRES-CreERT2; Rpap3flox/flox mice, as
expected from ex vivo organoid experiments (Fig. 7d). In the
colon, Rpb1 was nuclear in GFP− and GFP+ colonic crypts from
Lgr5-EGFP-IRES-CreERT2; Rpap3flox/flox mice at day 7 (Supple-
mentary Fig. 6a, b). At day 10–12, however, Rpb1 accumulated in
the cytoplasm of CBC stem cells and progenitors of GFP+ crypts,
but not in GFP− and GFP+ crypts from control animals (Fig. 8b
and Supplementary Fig. 6b). Thus, Rpap3 is necessary for Rpb1
biogenesis in both the small intestine and the colon, yet the effect
on Rpb1 appears later in the colon than in the small intestine.
To understand the reason for this delay, we compared the
cellular turnover between these tissues. For this, we injected the
nucleoside analog BrdU as a cell tracer into wild-type mice and
sacrificed them subsequently at different time points (Fig. 8c).
Two hours after injection, BrdU was incorporated exclusively by
CBC stem cells and progenitors in both the small intestine and the
colon (Fig. 8c). After one day, BrdU+ cells were detectable above
the TA compartment in the small intestine, while some remained
at the bottom of the crypt. BrdU+ cells then migrated to the tip of
the villus at day 3, and were eliminated at day 4, in accordance
with the previously described kinetics49. In contrast, in the colon,
migrating BrdU+ cells did not reach the crypt tip before day 4 and
were still detectable at day 5 (Fig. 8c). This illustrates a slower
cellular turnover in the colon than in the small intestine, which
correlates with a slower accumulation of Rpb1 in the cytoplasm of
colonic cells, smaller effects on client levels and milder phenotypes
at the tissular level (Fig. 7 and Supplementary Fig. 5).
RPAP3 expression correlates with colorectal cancer prognosis.
Our results so far suggest an intimate link between R2TP activity
and cell proliferation in the intestine. To test if R2TP is also
involved in pathogenic proliferation, we took advantage of the
CODREAD dataset (available at https://xenabrowser.net/).
Fig. 3 Rpap3 is required for proliferation in the small intestine. a Schematic representation of the experimental setting: 8-week-old mice of the indicated
genotype received two sequential injections of tamoxifen 24 h apart, and were analyzed 5 to 8 days after the first injection. 2 h before each sacrifice, BrdU
was injected intraperitoneally to detect cells in S-phase (thin arrows). b Schematic representation of a crypt from the small intestine, with CBC stem cells
(in green) sandwiched between Paneth cells (in brown) and progenitors forming the TA on top (purple). c Representative pictures of jejunum tissue
sections stained with HE (top) or by IHC with anti-Ki67 antibody (bottom, Ki67 signal is brown) at indicated days after the first tamoxifen injection. Pink
arrows point towards Paneth cells and black arrows towards CBC stem cells. Scale bar is shown in control HE panel. Each panel is representative of 8 to 12
animals analyzed in three independent experiments. Scale bar is identical for all panels and is 15 μm. d Representative pictures of jejunum taken from
control (boxed in blue) and VilCreERT2; Rpap3flox/flox animals (boxed in red), stained by IHC with anti-BrdU antibodies (brown arrows). n= 3–6 animals/
time point from two independent experiments. Scale bar is shown in control panel and is 50 μm. e Graph shows mean number of BrdU+ cells/crypt in
controls and VilCreERT2; Rpap3flox/flox animals at day 7. Each point represents the average number of BrdU+ cells calculated in n > 35 crypts from two
different zones per animal (n= 3). Mean values with S.E.M are indicated for each experimental group. Unpaired two-tailed t test with Welch’s corrections
(t= 11.66, df= 2) indicates significant difference between control and VilCreERT2; Rpap3flox/flox animals (p= 0.0073; n= 3). Source data are provided as a
“Source Data file”.
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Transcriptomic analyses showed a significant enrichment of
mRNAs encoding RUVBL1, RUVBL2, and RPAP3 in human
primary colorectal tumors (n= 380) as compared to normal tis-
sue (n= 51), in agreement with a previous report on a smaller
cohort50 (Fig. 9a).
This observation prompted us to test the expression of RPAP3
in CRC patient samples, using immunohistochemistry on Tissue
Microarrays (TMAs) sections from CRC patients and anti-
RPAP3 antibodies, which only detects human RPAP3 but not its
murine homolog51. We analyzed TMAs containing core tissues
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from patients diagnosed with CRC without pathological evidence
of nodal involvement and distant metastasis. 157 out of 177
(88.7%) cases expressed RPAP3 in the tumor cell cytoplasm. The
proportion of RPAP3-positive cells was in the range of 4–100%,
with a mean ± S.E. of 62.6% ± 2.6. To dichotomize the RPAP3
expression level in RPAP3high and RPAP3low, an optimal cut-off
value of 26% of positive tumor cells was chosen based on the
Receiver Operating Characteristic (ROC) analysis (AUC= 0.593;
Fig. 9b). The relationships between RPAP3 expression and
clinico-pathological parameters were investigated by Pearson’s χ2
test: RPAP3 expression negatively correlated with the tumor stage
of CRC (p= 0.049; Supplementary Tables 1, 2). Compared with
stage I tumors, the expression of RPAP3 was decreased in stage II
tumors (p= 0.049). Furthermore, compared with mucinous
carcinoma, the expression of RPAP3 was increased in CRC of
the adenocarcinoma type (p= 0.025). In addition, high RPAP3
expression was positively correlated with the occurrence of tumor
relapse (p= 0.003) and patients’ mortality (p= 0.036). Since
mTOR can influence CRC outcome52, we addressed its
contribution by IHC in tumors from the same patient cohort.
RPAP3 contributed only to 22% of mTOR expression level
(rho= 0.226, p= 0.007), which was not correlated with DFS
(Supplementary Fig. 7).
39 out of 123 (31.7%) patients with RPAP3high tumors and 6
out of 54 (11.1%) patients with RPAP3low tumors had disease
relapse. Analysis of Kaplan–Meier curves showed that patients
with RPAP3high tumors had a lower DFS rate than patients with
RPAP3low tumors (p= 0.037; Fig. 9b). Multivariate analyses of
DFS adjusted for other prognostic factors confirmed that RPAP3
expression was a significant prognostic parameter influencing
disease relapse (HR= 2.7: 95% CI, 1.2–6.5; p= 0.023; Supple-
mentary Table 3), but not the overall survival (OS) of patients.
These results provide evidence that high RPAP3-expression levels
in CRC tissues are associated with poor patient prognosis.
Discussion
Since its discovery in 2005, biochemical and structural studies
highlighted a chaperoning role for R2TP1,3. RPAP3 is a central
subunit within R2TP: it recruits the chaperones HSP70/90 via its
TPR domains, PIH1D1 through a short peptide domain and the
AAA+ ATPases RUVBL1/2 via its C-terminal domain7,10–12.
Overall, R2TP appears as a central hub for assembling multi-
subunit complexes by coordinating the activity of HSP70/90 with
that of RUVBL1/2. Most of the R2TP clients known so far have
been identified in mammalian cell lines4,15,17–20 and here we
validated several of them in the intestinal epithelium. This
includes PRPF8, part of the U5 spliceosomal snRNP, and NOP58,
a core component of box C/D snoRNPs required for ribosomal
biogenesis. Another class of R2TP substrates are the PIKKs22.
Several studies have documented that these large proteins are
stabilized by a trimeric adaptor called TTT, which itself interacts
with R2TP/HSP906,22,32,42,43,53. We show here that mTOR, ATR
and ATM depend on Rpap3 in intestinal crypts. Finally, a major
R2TP client is RNA PolII. This key enzymatic complex is
assembled in the cytoplasm prior to its nuclear translocation19.
The observed cytoplasmic accumulation of Rpb1 in Rpap3 KO
cells thus likely illustrates a defective assembly of RNA PolII.
Remarkably, invalidation of Rpap3 triggers p53 stabilization,
cell cycle arrest, apoptosis and destruction of the intestinal epi-
thelium. Transcription inhibition, DNA damage and defects in
ribosome biogenesis all activate p5354–57, yet p53 induction was
observed before any detectable alteration in R2TP client activity,
such as DNA damage (as monitored by γH2AX; Supplementary
Fig. 3a). This was even more striking in the colon, where p53 was
activated while R2TP clients were only mildly affected (Fig. 7).
Indeed, at day 6 and 7, p53 removal rescued the alterations in
small intestine, further showing that, at this point, loss of R2TP
client per se was not deleterious. To explain this result, we
hypothesize that unassembled R2TP clients trigger p53 activation.
For instance, exposed protein surfaces that are normally buried
into complexes could sequester the p53-E3 ligase MDM2, as
observed for unassembled ribosomal proteins58. And indeed, a
subset of ribosomal proteins was recently shown to bind Rpap359.
These ribosomal proteins could trigger p53 activation following
Rpap3 deficiency. In any case, the rescue of the Rpap3 KO phe-
notype by Trp53 removal was only transient. Defects in ATR,
RNA PolII, snoRNPs, and ribosome biogenesis might induce p53-
independent apoptosis and lead to small intestine degradation, as
described for ATR60 and proteins involved in housekeeping cel-
lular mechanisms such as transcription and translation61.
Ex vivo experiments showed that crypts from both small
intestine and colon depended on Rpap3 to form organoids, con-
firming the essential role of Rpap3 in proliferating cells. Interest-
ingly, we found that differentiated cells in the small intestine are
barely affected by Rpap3 removal, in contrast to the rapidly
dividing CBC stem cells and TA progenitors. Indeed, Rpb1 accu-
mulates in the cytoplasm of proliferating cells, while it remains
fully nuclear in the differentiated cells of the epithelium. We
propose that R2TP preferentially assembles the basic cellular
machineries in the proliferative compartment: CBC stem cells and
progenitors (Fig. 9c). Indeed, the high division rate of TA and CBC
stem cells (~10–12 h) likely requires high rates of protein synthesis,
folding and assembly, and accordingly, high R2TP activity62. In
contrast, non-dividing differentiated cells may rely on the pre-
existing machineries. Indeed, in Hela cells, many R2TP clients
(NOP58, PRPF8, EFTUD2, ATR, and mTOR) have an half-life that
is too stable to be measured (>24 h)63. Additional data support this
model of a preferential role of R2TP in proliferating cells. First,
R2TP is concentrated in CBC stem cells and progenitors of the
small intestine. Second, several R2TP clients are more abundant in
Fig. 4 Rpap3 invalidation induces CBC stem cells loss and apoptosis in the proliferative compartment of the small intestine. a, b Staining for Olfm4 in
the jejunum from control (top panel) and VilCreERT2; Rpap3flox/flox animals 7 days (a) or 6 to 8 days after the first tamoxifen injection. Panels are
representative for 2 to 4 animals/time point from at least two independent experiments. Scale bar is 20 μm in (a) and 50 μm in (b). c Schematic
representation of a crypt from the small intestine, with CBC stem cells (in green) sandwiched between Paneth cells (in brown) and progenitors forming the
TA on top (purple). d Representative micrographs of tissue sections immuno-stained for lysozyme, a specific marker of Paneth cells, in the jejunum of
control (top) and VilCreERT2; Rpap3flox/flox mice from day 6 to day 8. Panels are representative for 2 to 3 animals/time point from two independent
experiments. Scale bar, identical in all pictures, is 50 μm. e Total number of apoptotic cells identified by cleaved caspase 3 (cleaved cas3+) per surface
(mm2) of jejunum for each mouse analyzed, at day 6. Mean values with S.E.M are indicated for each experimental group. Unpaired two-tailed t test with
Welch’s correction indicates significant difference between controls and VilCreERT2; Rpap3flox/flox animals (p= 0.0384; t= 3.538, df= 3, n= 4).
f Micrographs are tissue sections stained for cleaved caspase 3 in the jejunum. In control animals, cleaved caspase 3+ cells (brown arrows) are mainly
detected at the tip of the villi, as a result of epithelial turnover (top panel). In the jejunum from VilCreERT2; Rpap3flox/flox animals, at day 6 and 7, cleaved
caspase 3+ cells were detected within the crypts (brown arrows). Panels are representative from 2 to 4 animals/time point, from two independent
experiments. Scale bar, identical in all pictures, is 50 μm. Source data are provided as a “Source Data file”.
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Fig. 5 Rpap3 deletion decreases expression of R2TP clients and leads to cytoplasmic accumulation of RNA polymerase II in intestinal crypts and TA
compartment. a Images are tissue sections of small intestines stained by immunohistochemistry (IHC) for Rpb1, the catalytic subunit of RNA polymerase
II, from control Rpap3flox/flox mice (blue frame, left panel), or VilCreERT2; Rpap3flox/flox animals at day 6 (red frame, right panel), with magnifications of crypts
(scale bars used for the two magnification insets are identical between blue and red frames). Note that the staining in stromal cells is nuclear in both wild-
type and VilCreERT2; Rpap3flox/flox animals (stromal cells do not express the Cre) and control epithelium, while it becomes cytoplasmic in the mutant
epithelium. Panels are representative for n= 6 animals from three independent experiments. Scale bar is 50 and 10 μm for insets, as shown in control
panels. b Schematical interpretation of the micrographs in (a). In control epithelial cells (blue), R2TP incorporates Rpb1 into RNA PolII, which is then
imported into the nucleus. In the absence of Rpap3 (red), neo-synthesized Rpb1 accumulates in the cytoplasm. c, d Western blot analysis of preparations
enriched for epithelial crypt cells from the jejunum of animals, sacrificed 6 days after the first tamoxifen injection. NOP58, EFTUD2, and PRPF8 (c), mTOR,
ATM, ATR, and TRRAP (d) were detected with specific antibodies. Tubulin and GAPDH were used as loading controls. Quantification of the signal ratios
are indicated on top of each lane (average for the control ratios was arbitrarily set to 100). Each lane was loaded with the lysate obtained from one animal
of the indicated genotype (n= 3 per genotype). Similar results were obtained with animals from at least two independent experiments. Apparent molecular
weights are indicated on the right. Source data are provided as a “Source Data file”.
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the intestinal proliferative compartment, including ATR,
U3 snoRNP and U5 snRNPs (Supplementary Fig. 3b, c). Third,
markers of RNA PolI activity, a potential R2TP client, accumulate
in the crypts and TA compartment with decreasing levels along the
crypt-villus axis56. Fourth, a recent transcriptomic analysis along
the crypt-villus axis detected mRNAs encoding ribosomal, splicing,
and transcription components at the very bottom of the villus, but
not along the villus or at the tip64.
A correlation between proliferation and sensitivity to Rpap3
removal further extends to the colon. Indeed, R2TP substrates
showed milder destabilization in the colon than in the small
intestine, while Rpb1 accumulation in the cytoplasm of
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recombinant colonic crypts was detected several days later than in
the small intestine. This correlates with the rate of epithelium
turnover, which is slower in the colon than in the small intestine
(Fig. 8c). In Drosophila, the RPAP3 ortholog, Spag, is required for
ovarian Germline Stem Cell (GSC) maintenance, but nor for the
surrounding non-dividing cells of the ovary27. This exemplifies
another case where RPAP3/Spag affects dividing stem cells, and
suggests a general role of R2TP in proliferation, especially of
active stem cells, across Metazoans.
Tumoral cells are particularly sensitive towards HSP90
inhibition65–67. This could be due to HSP90-dependent folding of
proteins involved in oncogenic signaling pathways. Furthermore,
an enhanced stability of the HSP90 interactome has been
described in some tumors and coined the “epichaperome”68. In
line with these, invalidation of a cytoplasmic HSP90 paralog
essential for spermatogenesis28 diminishes lung metastasis in a
murine model69. Yet, in clinical trials, HSP90 inhibitors have
been disappointing, showing cytotoxicity. One reason could be
the broad range of HSP90 substrates, which also includes tumor-
suppressors70,71. To bypass this problem Neckers and Workman
suggested to target HSP90 co-chaperones that are specific for a
given class of clients72. We propose to consider R2TP as a ther-
apeutic target, as a role for R2TP in intestinal carcinogenesis is
supported by several lines of evidences: (i) a higher expression of
mRNAs encoding R2TP subunits in colorectal tumors, as com-
pared to matching controls, (ii) high RPAP3 protein levels in
biopsies of CRC patients with poor diagnostic, (iii) a strong
dependency on RPAP3 in the proliferative compartment, and (iv)
sensitivity of cell proliferation in a p53-dependent and indepen-
dent context. R2TP is interesting not only as a therapeutic target
but also for prognostic purpose, since R2TP components RPAP3
and PIH1D1 were both identified as part of the epichaperome of
HSP90-sensitive tumors68.
In conclusion, we show that the R2TP chaperone plays a
crucial role in the intestinal epithelium homeostasis by promoting
proliferation of stem cells and progenitors (Fig. 9c).
Methods
Human colorectal sample collection and analysis. A total of 177 CRCs were
collected from patients surgically treated at the University “G. D’Annunzio”, Chieti,
Italy, between 1996 and 2010. Only the CRC patients who did not receive adjuvant
systemic therapy were included in the study. The median follow-up was 53 months
(range 3–238 months). During the follow-up, 25.4% of CRC patients (45 out of
177) had a disease relapse, while deaths were observed in 18.6% of CRC patients
(33 out of 177). Tumor stage was determined according to the American Joint
Committee on Cancer TNM staging system (8th edition). Histologically, each CRC
case was graded according to the criteria of the WHO classification of tumors of
the digestive system (4th edition). Patients and tumor characteristics are sum-
marized in Supplementary Tables 1, 2. The study was reviewed and approved by
the Institutional Research Ethics Committee Comitato Etico delle Province di
Chieti e Pescara e dell’ Università degli studi “G. D’Annunzio” di Chieti e Pescara
and written informed consent was obtained from all patients. The study complied
with all relevant regulations regarding the use of human study participants,
including the criteria set by the Declaration of Helsinki.
TMAs were constructed by extracting 2-mm diameter cores of histologically
confirmed neoplastic areas from the 177 CRC cases using a manual Tissue Arrayer
(MTA, Beecher Instuments, WI), as previously detailed73. It was conducted
following REMARK guidelines, as detailed in the REMARK checklist (see
Supplementary Note).
Mice generation and treatments. Mouse experiments were performed in strict
accordance with the guidelines of the European Community (86/609/EEC) and the
French National Committee (87/848) for care and use of laboratory animals,
comply the ARRIVE guidelines and were approved by the French Ministry of
Higher Education, Research and Innovation (reference APAFIS#18685) to be
performed in the institute animal facility (agreement # F3417216). Mice were
housed in temperature-controlled ventilated cages (20–22 °C) with a 12 h light-
dark cycle, with percentage of humidity between 45 and 55%, and maintained in
pathogen-free conditions in the institute animal facility. Rpap3wtsi/+ (Rpap3tm1a
(KOMP)Wtsi) mice were generated from ES cells (JM8A1.N3, C57BL/6 N genetic
background) generated by the trans-NIH KnockOut Mouse Project (KOMP) and
obtained from the KOMP Repository (www.komp.org). Genotyping was performed
by PCR amplification using primers F5, R5 and R6, on mouse tail genomic DNA
(gDNA—Supplementary Fig. 1a). All mice strains Rpap3tm1a(KOMP)Wtsi, Tg(CAG-
flpo)1Afst, Tg(Vil1-cre)20Syr, Tg(Vil1-cre/ERT2)23Syr, Lgr5(tm1cre/ERT2)Cle,
Trp53tm1Tyj/J (respectively referred to as Rpap3wtsi, FlpO, VilCre, VilCreERT2, Lgr5-
GFP-IRES-CreERT2, Trp53flox/flox),RPAP3flox/flox and compounds lines were
maintained on C57BL/6 background and bred in an SOPF animal facility, and
during the experiment in an SPF animal facility. Naive mice were minimum 6-
week-old and euthanized by CO2 and isoflurane. To activate the CreERT2, controls
and animals of interest received two intra-peritoneal (IP) injection of 2 mg
tamoxifen each. For BrdU incorporation assays, mice were intraperitoneally
injected with 100 µg Bromodeoxyuridine (BrdU) per gram of body weight. The
entire small intestine (cut in three parts) and colon were flushed with PBS, then
with neutral buffered formalin 10% and fixed in it for 24 h, dehydrated, and
embedded in paraffin.
Histology and immunostainings. TMA tissue sections were stained with a mouse
monoclonal antibody raised against RPAP3 (proprietary 19B11 antibody at 1:10
dilution) or an antibody against human mTOR (clone 7C10, 1:100 dilution;
overnight incubation; cat. number #2983; Cell Signaling). Antigen retrieval was
performed by microwave treatment at 750W (10 min) in 10 mmol/l sodium citrate
buffer (pH 6.0). The polymer kit (EnVision kit, K4003, Agilent) was used for signal
amplification. DAB (3,3-Diaminobenzidine) was used as chromogen. Anti-human
RPAP3 has been validated and previously published19,51. See Supplementary
Table 4.
For histological analysis on murine tissues, tissue sections (4 μm thick) were
deparaffinized and rehydrated. They were stained with hematoxylin and eosin
(H&E) or Periodic Acid Schiff staining (PAS) for preliminary analysis. For Ki67,
Cleaved-caspase 3 and γH2AX immunostainings, tissue sections were
deparaffinized, rehydrated, and subsequently subjected to heat induced antigen
retrieval in 10 mM sodium citrate buffer (pH 6) or 10 mM Tris HCl-1 mM
EDTA buffer (pH 9), depending on the antibody. Immunohistochemistry was
performed using a Dako autostainer (Dako, Glostrup, Denmark) by the RHEM
facility.
For immunohistochemistry (Rpb1, Lysozyme, Olfm4, Pih1d1), tissue slides
were incubated in 10 mM sodium citrate pH 6 (T0050, DiaPATH) or 10 mM Tris
HCl 1 mM EDTA pH 9 buffer for 20 min at 100 °C for antigen retrieval, depending
on the antibody. Endogenous peroxidase activity was inactivated with PBS—0.3%
hydrogen (#H1009, Sigma). After blocking in 2.5% blocking serum—5% BSA—5%
nonfat milk for 30 min at room temperature, tissue slides were incubated with
primary antibodies overnight at 4 °C. Then corresponding secondary antibody
Fig. 6 R2TP invalidation triggers p53-dependent and independent apoptosis. a Micrographs are tissue sections stained for p53 by immunofluorescence in
controls (top) and VilCreERT2; Rpap3flox/flox mice (bottom) at day 6, representative of n= 7 animals from three independent experiments. Nuclei were stained with
DAPI. Scale bar is 50 μm and is identical for all pictures. bMicrographs are tissue sections stained by immunofluorescence for p53 (Cy5, red) and lysozyme (Alexa
488, green), a marker of Paneth cells, in VilCreERT2; Rpap3flox/flox mice at day 6 (n=4). Nuclei were stained with DAPI. Scale bar, 50 μm, is identical for all pictures.
c Pictures of jejunum sections stained with HE (top) or by IHC with anti-Ki67 antibodies (bottom) in P53 KO (VilCreERT2; Rpap3flox/+; Trp53flox/flox), Rpap3 KO
(VilCreERT2; Rpap3flox/flox; Trp53flox/+) and double Rpap3 KO; P53 KO (VilCreERT2; Rpap3flox/flox; Trp53flox/flox) mice at day 6 to 8 after the first tamoxifen injection.
Pictures are representative for each single KO (n= 3) and double KO (n= 5–7) mice, from three independent experiments. Scale bar, 50 μm, is identical for all
pictures. d Pictures of jejunum sections stained by IHC with anti-Rpb1 antibody in control, P53 KO (VilCreERT2; Rpap3flox/+; Trp53flox/flox), Rpap3 KO (VilCreERT2;
Rpap3flox/flox; Trp53flox/+) and double Rpap3 KO; P53 KO (VilCreERT2; Rpap3flox/flox; Trp53flox/flox) mice at day 6 following tamoxifen injection. Pictures are
representative of n= 3 for each single KO, n= 7 for double KO, from two different experiments. Scale bar, 50 μm, is identical for all pictures. e Total number of
apoptotic cells at day 6 per surface (mm2) of the jejunum for each mouse analyzed. n= 2 for wild type, n= 3 for each single KO, n= 7 for double KO, from two
different experiments. Mean values with S.E.M are indicated for experimental groups with n> 3. One-way ANOVA analysis (p=0.0006) with Bonferroni’s multiple
comparison post-test (**p< 0.001). Source data are provided as a “Source Data file”.
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reagents (ImmPRESSTM kit, Vector Laboratories), directed against mouse, goat or
rabbit were used for detection.
Incorporation of BrdU in proliferating intestinal epithelial cells was detected
using an anti-BrdU antibody (Biolegend, 1:100) after deparaffinization of the
tissues, antigen retrieval in 10 mM citrate buffer pH 6, as described above, and
DNA denaturated using 2N HCl for 1H at 37 °C followed by an incubation in 0.1M
borax buffer pH 9. Revelation was performed using the Avidin/Biotin Vectastain
System kit (Vectorlab, USA) according to the manufacturer protocol. After
neutralization of the endogenous peroxidase activity, the sections were incubated
with the primary antibodies.
Antibody were visualized using the Envision® system (Dako). 3,3’-
Diaminobenzidine (Dako) was used as the chromogen and the sections were lightly
counterstained with hematoxylin. Histological slides were scanned using the
Nanozoomer 2.0 HT scanner with a ×40 objective, and visualized with the NDP.
view2 software (both from Hamamatsu).
For p53 immunofluorescence, paraffin-embedded tissues were cut into 3-µm-
thick sections, mounted on slides, then dried at 37 °C overnight. Staining was
performed on the Discovery Ultra Automated IHC staining system from Roche
Ventana. Following deparaffination with the Discovery EZ Prep solution at 75 °C
for 24 min, antigen retrieval was performed at 95 °C for 16 min using the Discovery
CC1 buffer. After blocking in TBS, 10% goat serum, 5% BSA, 5% milk, 0.3% triton
X100, the slides were incubated with a rabbit anti-p53 antibody 37 °C for 60 min
(Leica, P53-CM5P-L, 1∶250). Signal enhancement was performed using the
OmniMap anti-Rabbit HRP kit (Roche, 760-4457) then with the Cy5 Kit (Roche,
760-238). For double immune-stainings, slides were stripped by heating before
incubation with anti-lysozyme antibody.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24792-4 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:4810 | https://doi.org/10.1038/s41467-021-24792-4 | www.nature.com/naturecommunications 13
For Rpb1/GFP immunofluorescence, antigen retrieval with 1 mM EDTA was
performed for 30 min at 99 °C. Slides were blocked with 5% goat serum-PBS—0.3%
triton X-100 for 1 h at RT then incubated with primary antibodies overnight at
4 °C. Samples were incubated in a DAPI solution combined with the secondary
antibodies for 1 h at RT. Slides were mounted with cover slip in ProLong Gold
Antifade Mounting media or Vectashield. Fluorescent images were acquired by the
Axioscan 40x camera and analyzed with ZEN (both from Zeiss), brightfield upright
Zeiss Axioimager Z1 using the Metamorph software, or on the inverted Confocal
SP5 (Leica) using the Leica LAS AF software.
All antibodies used for immunostainings are described in Supplementary
Table 4 and have been validated by the manufacturers, independent groups (see
https://www.citeab.com), the RHEM platform, our previous work (Rpb1)19 or
this study.
For β-galactosidase activity, small intestines and colons cryo-preserved were cut
to slices of 10 μm thickness. Samples were treated with 0.5% glutaraldehyde for
10 min at room temperature, followed by 24 h of incubation at 37 °C in a staining
solution containing 1 mg/ml X-gal, 5 mM potassium ferricyanide (K3Fe(CN)6),
5 mM potassium ferrocyanide (K4Fe(CN)6) and 2 mM MgCl2, 0.1% Triton X100
in PBS. Samples were washed in PBS for 5 min, counterstained with Nuclear Fast
Red and briefly rinsed with dH2O before mounting using an aqueous mounting
solution (Aquatex, 108562;Merck).
U3 snoRNA FISH. Small intestines and colons cryo-preserved were cut to slices of
10 μm thickness. The frozen sections were fixed in PBS/paraformaldehyde 4% at
room temperature for 60 min, followed by permeabilization with ethanol 70%,
overnight at 4◦C. In situ hybridization was performed overnight with Cy3 labeled
oligonucleotides against U3 (AT*AGAACGATTCAACT*CATCAACGCGGGT*G
CACTTGGCTTTCT*A).
After several washes, the slides were staining with DAPI and mounted in
Vectashield.
Microscopy and imaging. Histological slides were scanned using the Nanozoomer
2.0 HT scanner with a ×40 objective, and visualized with the NDP.view2 software
(Hamamatsu). Fluorescent images were acquired with Axioscan using ZEN soft-
ware (Zeiss), brightfield Axioimager Z1 (Zeiss) using the Metamorph software or
on the inverted Confocal SP5 (Leica) using the Leica LAS AF software. Images were
processed with Adobe Photoshop CS6.
Isolation of epithelial cells from the intestine. Small intestines and colons were
isolated and flushed with cold PBS. Colon and the three intestine fragments were
cut open length-wise, then kept in 10 ml cold wash buffer (PBS, 2% FBS and
antibiotics). Tubes were shaken several times to wash the fragments and put into
15 ml falcon tube containing 10 ml CE buffer (PBS, 1% BSA, 1 mM DTT, 1 mM
EDTA, 5.6 mM glucose). Tubes were placed on a vertical shaker at 37 °C for
30 min. After removing tissue, cells were collected by centrifugation at 1410 rpm
for 7 min. They were washed in 10 ml wash buffer. Collected cells were split in
different tubes and stored at −80 °C.
To separate villi and crypt cells, after PBS wash, villi were gently scraped off
using a glass cover slip. Free villi fractions were collected by pipetting in 1 ml of
cold PBS. The rest of tissue (the crypts were still attached) was incubated with
10 ml CE lysis buffer to dissociate and collect crypt cells.
Organoids. Colons and small intestines were dissected, inverted on a stick, cut
longitudinally then washed extensively in cold PBS-supplemented with penicillin/
streptomycin. After cutting them in 0.3 cm long pieces, they were incubated in
10 ml of cold PBS. Pieces were washed 5 to 10 times in cold PBS with antibiotics
and then treated for 30 min at 4 °C with PBS-25mM EDTA for the colon and PBS-
2-mM EDTA for the small intestine. After sedimentation, the pieces were washed
four times in 10 ml of cold PBS. For each wash, corresponding to Fraction 1 to 4,
the supernatant was strained in a 70 µm mesh filter. Each fraction was then cen-
trifuged at 390 g for 7 min and checked for the presence of well-formed crypts
under the microscope. Usually fractions 3 and 4 were used for the organoid culture.
200 crypts were resuspended in 50μl of Matrigel in WENR (DMEM-F12 media
supplemented by WNt3a, EGF, Noggin, R-spondin-1) media for the colon and
ENR (DMEM-F12 media supplemented by EGF, Noggin, R-spondin-1) media for
the small intestine and microscopically inspected once a day, as described47.
Western blots. Protein extracts were prepared from epithelial cell preparations
by lysis in cold RIPA buffer (50 mM Tris pH8, 150 mM NaCI, 1% NP40, 0.5%
deoxycholate) supplemented with inhibitors. Protein lysates were separated on a
gradient 4–15% SDS-PAGE (BioRad) and transferred to a nitro-cellulose
membrane (Amersham Protran 0.2 µm NC). Membranes were blocked with TBS
—2.5% nonfat milk (w/v)—0.05% Tween and incubated with the appropriate
primary antibodies, followed by an incubation with secondary antibodies con-
jugated to the horseradish-peroxidase or a fluorophore. ECL was revealed with
Amersham ECL 600 camera and fluorescence with the Amersham Typhoon
scanner.
Primary antibodies from Cell Signaling: ATM clone D2E2 (CST 2873S) rabbit
at 1/1000, ATR clone E1S3S (CST 13934S) rabbit at 1/1000, mTOR (CST 2972S)
rabbit 1/1000, p53 clone 1C12 (CST2524S) mouse 1/1000; PRPF8 (sc-30207, Santa
Cruz) rabbit 1/200; from Abcam: EFTUD2 (ab72456) rabbit 1/2000, GAPDH
(ab8245 6C5) mouse 1/10000; from Sigma: NOP58 (HPA018472) rabbit 1/100,
RPAP3 (SAB1411438) rabbit 1/1000, α-Tubulin (I2G10) mouse 1/500; from
Proteintech PIH1D1 (19425-1-AP) rabbit 1/1000; from Bertin TRRAP (G01043
murine clone 2D5) mouse 1/1000 (a generous gift from L. Tora). We validated
anti-PRP8 in17 and anti-TRRAP using a proprietary cell line with degradable
TRRAP. All other antibodies have been validated by the manufacturers, as well as
by independent groups which reported their use in several publications, notably in
the CiteAb platform (https://www.citeab.com/) and are described in
Supplementary Table 4.
DNA extraction. Samples were incubated in 100 µl of alkaline lysis buffer (NaOH
25 mM, EDTA 0.2 mM) at 92 °C for 20 min, kept on ice for 10 min. Then 100 µl of
neutralizing reagent (40 mM Tris HCl pH 5) was added to the samples. 2 µl were
used for each PCR.
Southern blot. Briefly, ES cells were incubated overnight at 65 °C in 100 mM
Tris HCl pH8.8—5 mM EDTA—0.2% SDS—200 mM NaCl with 0.1 mg/ml
proteinase K in a humid chamber. On the following morning, lysates were
extracted twice with phenol pH7.0–8.0 and once with chloroform then pre-
cipitated in NaCl/EtOH. Following recovery, 10–15 μg of genomic DNA were
digested for 24 to 48 h with appropriate highly concentrated restriction enzymes
(40–50 U/μl–10 U/μg of gDNA). The analysis was performed by Southern blot as
described in74.
PCR for genotyping. Initial denaturation: 95 °C (2 min), Denaturation 95 °C (30 s),
Annealing 55 °C (45 s), Extension 72 °C (45 s), and Final extension: 72 °C (2 min)
for 35 cycles. Primers: RPAP3: F5 (GGTGCCACAGTGTGAGTG), R5 (TGCC
TCCTGACTCACTACAG, R6 (ACCGTGTCGCTACGTCACTGCG); CREERT2-F
(TTACGGCGCTAAGGATGACT), CREERT2-R (AAGGCCAGGCTGTTCTT
CTT); P53-F (TGC TAG ATG CTT AGG GCT GC), P53-R (GAC TGG CCC TTC
TTG GTC TT). Primers are reported in the Supplementary Table 5.
Statistical analysis. Transcriptomic analysis of R2TP subunits in human samples
were extracted from the CODREAD cohort available at UCSC Xena platform for
Fig. 7 Rpap3 is required in the colon. a Representative micrographs of colon sections stained by Periodic Acid Schiff stain (PAS, for labeling of goblet
cells), IHC for Ki67 and CD44v6 (a marker of the colonic stem cells) and IF for p53, in controls Rpap3flox/flox (left) and VilCreERT2; Rpap3flox/flox mice (right)
at day 8 (n= 4 from at least two independent experiments). Scale bars are 50 μm. b Western blot analysis of colonic epithelial cells from animals,
sacrificed 7 days after the first tamoxifen injection. mTOR, ATM, and tubulin were detected with specific antibodies. Quantification of the signal ratios are
indicated on top of each lane (average for the control ratios was arbitrarily set to 100). Each lane was loaded with the lysate obtained from one animal of
the indicated genotype (representative for n= 5 KO animals in one experiment). Molecular weights are indicated on the right. c Micrographs are tissue
sections stained by IHC for cleaved caspase 3 in Rpap3flox/flox (blue) and VilCreERT2; Rpap3flox/flox (red) mice at day 6, representative for n= 4 from two
different experiments. Total number of apoptotic cells at day 8 per surface (mm2) of the jejunum for each mouse analyzed. Mean values with S.E.M are
indicated for each experimental group. Unpaired two-tailed t test with Welch’s correction indicates significant difference between controls and VilCreERT2;
Rpap3flox/flox animals (p= 0.0234, t= 2.625, df= 5). Scale bar is 50 μm. d Picture of organoids cultures. Crypts from small intestine (top) and colon
(bottom) were prepared from Rpap3flox/flox (blue) and VilCreERT2; Rpap3flox/flox (red) mice 3 days after tamoxifen injection (n= 3). Identical number of
crypts were seeded and organoids culture were monitored every day. Organoids from control animals started budding after 72 h in culture for small
intestine crypts and 96 h for colonic crypts. Organoids generated from VilCreERT2; Rpap3flox/flox animals degenerated in culture before budding. Scale bar
are 100 μm for all pictures and 20 μm for organoid insets. Source data are provided as a “Source Data file”.
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Fig. 8 Rpap3 activity in intestinal crypts correlates with tissue turnover. a Schematic representation of the experimental setting. Eight-week-old Lgr5-
GFP-IRES-CreERT2; Rpap3flox/flox mice received five sequential intra-peritoneal injections of tamoxifen and were analyzed 7 or 10 days after the first injection.
In this genetic model, the Cre is expressed in the Lgr5+ CBC stem cells labeled by GFP (see scheme on the right). b Representative images of tissue
sections labeled by immunofluorescence with antibodies against GFP (green) and Rpb1 (red), with DAPI counter-staining of nuclei (blue). Please note the
mosaic expression of GFP. Panels are representative for 5 animals/time point from two independent experiments. White arrow: GFP+ crypts. Asterisks:
GFP− crypts. Scale bars (40 or 20 μm) are identical for matching panels. c Images are intestine tissue sections of wild-type animals stained for BrdU.
Animals received one BrdU injection and were sacrificed at the indicated time point. The experiment was repeated twice (2 to 4 animals/time point from
two different experiments). Scale bars (50 μm) are identical for all pictures.
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public and private cancer genomics data visualization and interpretation https://
xenabrowser.net/75. One-way ANOVA test was performed using GraphPad
Prism 5.0.
For the outcome endpoints of human data, the DFS was defined as the
measure of time after treatment during which one of the following events
occurred: relapse at local or distant sites, or intercurrent death without
recurrence. OS was defined as the time between surgery and death from any
cause. Survival curves were analyzed by the Kaplan–Meier method and
compared using the log-rank test. Cox’s proportional hazards model, adjusted
for other prognostic factors (i.e., gender, tumor location, tumor grade, tumor
stage, and RPAP3 status), was used to evaluate the association of RPAP3
expression with outcome. Spearman correlation was used to analyze the
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correlation between the expression of RPAP3 and mTOR. Statistical analysis
were performed with the SPSS 15.0 (SPSS Inc., Chicago, IL).
All other statistical analysis were performed employing GraphPad Prism 5.0.
Sample availability
Mouse sperm for the different strains is available upon request, as
well as proprietary antibodies.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The datasets analyzed during the current study for the transcriptomic analysis of R2TP
subunits in human samples (Fig. 9a) used the UCSC Xena platform for public and private
cancer genomics data visualization and interpretation available at https://xenabrowser.
net/75. The datasets concerning the patient biopsies (Fig. 9b, Supplementary Fig. 7) are
not publicly available because the database contains sensitive information that could
compromise patient privacy but are available. Access to the original clinical records are
subject to restrictions due to legal and privacy reasons. It must be authorized by the
single patient or patient’s legally authorized representative, and a specific request must be
issued to: Direzione Medica/Presidio Ospedaliero “SS. Annunziata”; ASL02 di Lanciano-
Vasto-Chieti/Via Dei Vestini/66100 Chieti (Italy). Timeframe for response is usually
1 month. The remaining datasets that support the findings of this study are available in
the Article, Supplementary Information, or, together with details about the experimental
procedures, are available from the corresponding author upon reasonable request. Source
data are provided with this paper.
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